Enhanced Recovery After Surgery for Sarcoma
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to demonstrate the efficacy of implementing the enhanced recovery after surgery (ERAS) pathway in a prospective manner to patients undergoing surgical treatment for extremity sarcoma.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is Enhanced Recovery After Surgery (ERAS) generally safe for humans?
The research articles provided do not contain specific safety data for Enhanced Recovery After Surgery (ERAS) or similar protocols like Enhanced Recovery Protocol or Fast-Track Protocol. They focus on surgical complications and reconstruction strategies for sarcoma, but do not address the safety of ERAS protocols.12345
How is the Enhanced Recovery After Surgery (ERAS) treatment different for sarcoma patients?
The Enhanced Recovery After Surgery (ERAS) treatment is unique because it is a comprehensive program designed to improve recovery after surgery by using a combination of strategies, such as optimizing nutrition, pain management, and mobilization, tailored specifically for patients with soft tissue sarcoma. This approach differs from traditional methods by focusing on enhancing overall recovery rather than just treating the sarcoma itself.678910
What data supports the effectiveness of the treatment Enhanced Recovery After Surgery (ERAS) for sarcoma?
Research shows that ERAS programs, which help patients recover faster after surgery, have been effective in reducing hospital stay and improving recovery in surgeries for conditions like colorectal and gastric cancer. This suggests that similar benefits might be seen when ERAS is used for sarcoma surgery.1112131415
Who Is on the Research Team?
Joshua M Lawrenz, MD
Principal Investigator
Vanderbilt Medical Center
Are You a Good Fit for This Trial?
This trial is for adult patients over 17 years old at Vanderbilt University Medical Center who are about to have surgery for suspected sarcoma in an arm or leg. It's open to those who've never taken opioids and those who currently use them. Non-English speakers and patients not having surgery are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Perioperative Treatment
Administration of a perioperative non-narcotic, multimodal pain management pathway
Follow-up
Participants are monitored for safety and effectiveness after treatment, including pain scores, limb function, and clinical outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Recovery After Surgery
Enhanced Recovery After Surgery is already approved in European Union, United States, Canada, China for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Joshua Lawrenz
Lead Sponsor